Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting
NCT02107495 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 191
Last updated 2016-04-19
Summary
To establish the performance characteristics of the Samsung LABGEO IVD-A20 CHF Test in intended use settings, by comparing test results of the A20 CHF Test with results obtained from an FDA-cleared comparator assay.
Conditions
- Congestive Heart Failure
Interventions
- DEVICE
-
Samsung LABGEO IVD-A20 CHF Test
Sponsors & Collaborators
-
Nexus DX
collaborator INDUSTRY -
Samsung Electronics
lead INDUSTRY
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-03-31
- Primary Completion
- 2015-02-28
- Completion
- 2015-02-28
Countries
- United States
Study Locations
More Related Trials
-
Extended IASD Investigation: REDUCE LAP-HF IV
NCT04632160 ·Status: WITHDRAWN ·Phase: NA
-
Cardiovascular Diagnosis Using µ-Cor - an Interventional Pilot Trial
NCT02700191 ·Status: WITHDRAWN ·Phase: NA
-
Identifying and Facilitating Ventricular Recovery on Mechanical Support
NCT00687856 ·Status: COMPLETED
-
Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy
NCT02790242 ·Status: TERMINATED
-
Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure
NCT01001312 ·Status: TERMINATED ·Phase: PHASE4
-
Monitoring Outpatient Blood VolumE in Heart Failure
NCT04660396 ·Status: COMPLETED
-
Assessment of Safety and Accuracy of the Microtech System in Patients Undergoing Left Ventricular Assist Device Implantation
NCT06682910 ·Status: RECRUITING ·Phase: NA
-
A Clinical Trial to Evaluate the HeartWare MVAD® System (MVAdvantage)
NCT01831544 ·Status: TERMINATED ·Phase: NA
-
An Automated Continual Water Removal System in Patients With Advanced Diuretic Resistant Heart Failure
NCT05140759 ·Status: TERMINATED ·Phase: NA
-
Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management
NCT01452802 ·Status: COMPLETED
-
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement
NCT01240902 ·Status: COMPLETED ·Phase: NA
-
Resynchronization for Ambulatory Heart Failure Trial in Patients With Preserved LV Function
NCT04582578 ·Status: WITHDRAWN ·Phase: NA
-
REDUCE LAP-HFREF TRIAL
NCT03093961 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Outcomes of a Novel Magnetically Levitated LVAD: a Multicenter Analysis
NCT06596499 ·Status: COMPLETED
-
Stimulation of the Diaphragm in Patients With Severe Heart Failure Following Heart Surgery
NCT00769678 ·Status: COMPLETED ·Phase: NA
-
Jarvik 2000 Heart as a Bridge to Cardiac Transplantation - Pivotal Trial
NCT00591799 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Indicor Validation
NCT03430102 ·Status: COMPLETED
-
Cardiac Output Pulmonary Arterial Catheter Compared to FloWave™ 1000
NCT00665301 ·Status: COMPLETED
-
Dawneo Neoblazar® Transcatheter Tricuspid Valve Edge-to Edge Repair System Pivotal Clinical Trial in Patients With Severe Tricuspid Regurgitation
NCT05497141 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the HeartWare Left Ventricular Assist Device for the Treatment of Advanced Heart Failure
NCT00751972 ·Status: COMPLETED ·Phase: NA
-
Assessing the Effects of Mechanical Unloading on Repair Version-1
NCT06026215 ·Status: COMPLETED
-
The Medtronic TAVR 2.0 US Clinical Study
NCT02738853 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Surgical Mitral Valve Repair Versus Medical Treatment for People With Significant Mitral Regurgitation and Non-ischemic Congestive Heart Failure
NCT00608140 ·Status: TERMINATED ·Phase: PHASE3
-
Cardiovascular Improvements With MV ASV Therapy in Heart Failure
NCT01953874 ·Status: TERMINATED ·Phase: NA
-
Corheart 6 Left Ventricular Assist System Prospective, Multicenter, Single-arm Clinical Evaluation Trial
NCT05353816 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA